CoChat

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens

Open access
Kalaora, Shelly, Barnea, Eilon, Merhavi-Shoham, Efrat, Qutob, Nouar, Teer, Jamie K., Shimony, Nilly, Schachter, Jacob, Rosenberg, Steven A., Besser, Michal J., Admon, Arie, Samuels, Yardena · 2016 · Oncotarget
Cited by 148

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

// Shelly Kalaora 1 , Eilon Barnea 2,* , Efrat Merhavi-Shoham 3,* , Nouar Qutob 1 , Jamie K. Teer 4 , Nilly Shimony 3 , Jacob Schachter 3 , Steven A. Rosenberg 5 , Michal J. Besser 3,6,** , Arie Admon 2,** and Yardena Samuels 1 1 Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 2 Department of Biology, Technion, Haifa, Israel 3 The Ella Lemelbaum Institute for Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel 4 Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 5 National Cancer Institute, NIH, MD, USA 6 Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel * These authors have contributed equally to this work ** These authors have contributed equally to this work Correspondence to: Yardena Samuels, email: // Keywords : HLA, TILs Received : November 26, 2015 Accepted : December 30, 2015 Published : January 20, 2016 Abstract The antigenicity of cells is demarcated by the peptides bound by their Human Leucocyte Antigen (HLA) molecules. Through this antigen presentation, T cell specificity response is controlled. As a fraction of the expressed mutated peptides is presented on the HLA, these neo-epitopes could be immunogenic. Such neo-antigens have recently been identified through screening for predicted mutated peptides, using synthetic peptides or ones expressed from minigenes, combined with screening of patient tumor-infiltrating lymphocytes (TILs). Here we present a time and cost-effective method that combines whole-exome sequencing analysis with HLA peptidome mass spectrometry, to identify neo-antigens in a melanoma patient. Of the 1,019 amino acid changes identified through exome sequencing, two were confirmed by mass spectrometry to be presented by the cells. We then synthesized peptides and evaluated the two mutated neo-antigens for reactivity with autologous bulk TILs, and found that one yielded mutant-specific T-cell response. Our results demonstrate that this method can be used for immune response prediction and promise to provide an alternative approach for identifying immunogenic neo-epitopes in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6960

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 148

Metadata

Authors
Kalaora, S., Barnea, E., Merhavi-Shoham, E., Qutob, N., Teer, J. K., Shimony, N., Schachter, J., Rosenberg, S. A., Besser, M. J., Admon, A., & Samuels, Y.
Venue
Oncotarget
Published
2016-01-20
Volume
7
Issue
5
Pages
5110-5117
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2271526964
Cited by
148
References
2
FWCI
11.59
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. https://app.cochat.ai/papers/10.18632/oncotarget.6960
The paper
Kalaora, S., Barnea, E., Merhavi-Shoham, E., Qutob, N., Teer, J. K., Shimony, N., Schachter, J., Rosenberg, S. A., Besser, M. J., Admon, A., & Samuels, Y. (2016). Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget. https://doi.org/10.18632/oncotarget.6960

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.